Earnings call Castle Biosciences exceeded 2025 revenue guidance with $344.2M in revenue, driven by 37% core test volume growth and standout 86% growth in TissueCypher. Management projects 2026 revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results